Justin Petrone

Called Personal Access to Genome and Analysis of Natural Traits, or PAGEANT, the platform enables users to analyze and interpret their genomic data at no cost.

The €12 million European Union-backed effort, called BeYond-COVID, commenced last month and will run through October 2024.

The firm recently debuted its offering, which consists of assay kits, an integrated diagnostic platform, and a results management system.

Investigators are exploring mechanisms to make data available, while acknowledging that scaling up and sustaining the initiative will take place beyond 2022.

At the European Society of Human Genetics meeting, experts discussed how to resolve questions raised by the EU's General Data Protection Regulation around genomic data sharing.

Experts agreed that more must be done to address disparities not only in research but also in the implementation of findings in local healthcare settings.

Both studies relied on data collected via the FinnGen project, an international effort to collect genotype and health registry data on 500,000 people in Finland by 2023.

DeCode has identified markers associated with osteoarthritis and autoimmune thyroid disease and is developing a calculator to predict five-year mortality risk.

The effort relied on Estonian Biobank data, the sequencing of archaic genomes, and diverse analytical methods to assess the relatedness of the kindred populations.

The program is expected to aid increased investments in RNA-based products, which the organizers maintain are currently limited by manufacturing constraints.